Avoiding Pitfalls When Responding to Government Regulators
On May 10, 2011, a federal district court granted a rare Rule 29 Motion and dismissed charges against an attorney accused of obstructing an FDA investigation. Join other in-house counsel and watch the case play out as litigators from our White Collar and Government Enforcement Practice Group present the prosecution and defense in a mock closing, followed by an interactive discussion and analysis, including practical, ethical and long-term suggestions on how to meet the expectations of government regulators, protect your company—and protect yourself.
Breakout discussions focusing on the issues affecting various regulated industries and how best to communicate with the government in a way that advocates a company's cause will follow the general session.
Location: The Hub Cira Centre, 2929 Arch Street, Philadelphia, PA
2:30 p.m. – 3:00 p.m. Registration
3:00 p.m. – 4:00 p.m. General Session
4:00 p.m. – 5:00 p.m. Industry-Focused Breakout Discussions
5:00 p.m. – 6:30 p.m. Cocktail Reception
General Session Speaker: Nicholas J. Nastasi, Saul Ewing
Health Industry Discussion Speaker: David R. Moffitt, Saul Ewing
Insurance Industry Discussion Speakers: Amy S. Kline, Saul Ewing, Cynthia L. Randall, CIGNA
Life Sciences Industry Discussion Speakers: Deborah L. Spranger, Moderator, Saul Ewing, Valli F. Baldassano, Cephalon, Stuart L. Fullerton, AstraZeneca, Christopher R. Hall, Saul Ewing
Two PA Ethics CLE credits offered.